Speech-Language Pathologists in Rindge, NH Accepting Medicare
1 Speech-Language Pathologists found. Showing 1 - 1
 Miss Francesca E Day, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 58 School St, Rindge, NH 03461 Phone: 603-899-3363 |
News Archive
GlaxoSmithKline receives FDA approval for cervical cancer vaccine
GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has approved CERVARIX® [Human papillomavirus bivalent (types 16 and 18) vaccine, recombinant] for the prevention of cervical pre-cancers and cervical cancer associated with oncogenic human papillomavirus (HPV) types 16 and 18 for use in girls and young women (aged 10-25).
ALS TDI, Biogen Idec and UCB enter agreement to study anti-CD40L antibody for ALS
The ALS Therapy Development Institute today announced a research agreement with Biogen Idec and UCB Pharma SA to investigate the use of an anti-CD40L antibody as a potential therapy for Amyotrophic Lateral Sclerosis, also known as Lou Gehrig's or Motor Neuron Disease.
Nanoparticles' movements reveal whether they can hit intended cancer targets
Targeted drug-delivery systems hold significant promise for treating cancer effectively by sparing healthy surrounding tissues. But the promising approach can only work if the drug hits its target.
Viewpoints: Debt estimates and Medicare plans; Sen. McConnell on fate of health law
Debt projections released Tuesday by the Congressional Budget Office illustrate three fiscal paths: dangerous, dumb and smart. ... President Obama has called for a balanced solution but has neither proposed serious tax reform nor adequately outlined the ways in which he would get entitlement spending, particularly Medicare, under control. The position of most Republicans, on the presidential campaign trail and in Congress, is wildly less responsible.
Spectrum Pharmaceuticals to present ZEVALIN data at ASH Meeting
Spectrum Pharmaceuticals, Inc., a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced a total of 11 ZEVALIN related data presentations (five oral, six posters) at the 52nd Annual Meeting of the American Society of Hematology (ASH), being held at the Orange County Convention Center in Orlando, Florida, December 4-7, 2010.
› Verified 1 days ago